Abstract
The PHG Foundation led a multidisciplinary program, which used results from COGS research identifying genetic variants associated with breast, ovarian and prostate cancers to model risk-stratified prevention for breast and prostate cancers. Implementing such strategies would require attention to the use and storage of genetic information, the development of risk assessment tools, new protocols for consent and programs of professional education and public engagement.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care
Trials Open Access 27 September 2022
-
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
BMC Cancer Open Access 06 May 2022
-
A polygenic risk score for multiple myeloma risk prediction
European Journal of Human Genetics Open Access 30 November 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Anonymous. Nat. Genet. published online; doi:10.1038/ng.2592 (27 March 2013).
Michailidou K . et al. Nat. Genet. published online; doi:10.1038/ng.2563 (27 March 2013).
Pharoah, P.D.P. et al. Nat. Genet. published online; doi:10.1038/ng.2564 (27 March 2013).
Eeles, R.A. et al. Nat. Genet. published online; doi:10.1038/ng.2560 (27 March 2013).
Rose, G. Int. J. Epidemiol. 14, 32–38 (1985).
Burton, H., Sagoo, G.S., Pharoah, P. & Zimmern, R.L. Ital. J. Public Health 9, 4 (2012).
Garcia-Closas, M. et al. Nat. Genet. published online; doi:10.1038/ng.2561 (27 March 2013).
Bojesen, S.E. et al. Nat. Genet. published online; doi:10.1038/ng.2566 (27 March 2013).
French, J.D. et al. Am. J. Hum. Genet. published online; doi:10.1016/j.ajhg.2013.01.002 (27 March 2013).
Shen, H. Nat. Comm. published online; 10.1038/ncomms2629 (27 March 2013).
Permuth-Wey, J. et al. Nat. Comm. published online; doi:10.1038/ncomms2613 (27 March 2013).
Kote-Jarai, Z. et al. Hum. Mol. Genet. published online; doi:10.1093/hmg/ddt086 (27 March 2013).
Pashayan, N. et al. Br. J. Cancer 104, 1656–1663 (2011).
Fredholm, H. et al. PLoS ONE 4, e7695 (2009).
Lin, D.W., Porter, M. & Montgomery, B. Cancer 115, 2863–2871 (2009).
Chowdhury, S. et al. Genet. Med. published online; doi:10.1038/gim.2012.167 (14 February 2013).
Dent, T. et al. Public Health Genomics published online; doi:10.1159/000345941 (26 January 2013).
UK Parliament. Human Tissue Act 2004 Chapter 30 (The Stationery Office, London, 2004).
Antoniou, A. et al. Am. J. Hum. Genet. 72, 1117–1130 (2003).
Zheng, W. et al. Nat. Genet. 45, 191–196 (2013).
Independent UK Panel on Breast Cancer Screening. Lancet 380, 1778–1786 (2012).
Acknowledgements
H.B., S.C., T.D. and A.H. were supported by the PHG Foundation. The PHG Foundation is the working name of the Foundation for Genomics and Population Health, a charitable company registered in England and Wales: Charity 118664, Company 5823194. N.P. is supported by a Cancer Research UK Clinician Scientist Fellowship. This work is part of the COGS program, funded by the seventh Framework Programme of the European Commission under grant agreement 223175 (HEALTH-F2-2009-223175).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Burton, H., Chowdhury, S., Dent, T. et al. Public health implications from COGS and potential for risk stratification and screening. Nat Genet 45, 349–351 (2013). https://doi.org/10.1038/ng.2582
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2582
This article is cited by
-
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
BMC Cancer (2022)
-
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care
Trials (2022)
-
A polygenic risk score for multiple myeloma risk prediction
European Journal of Human Genetics (2022)
-
European women’s perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study
BMC Cancer (2020)
-
The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan
Trials (2020)